BSE Sensex 30 Stocks Regulatory Filings — March 17, 2026

17-03-2026

Tata Steel's Board approved the Scheme of Amalgamation of its wholly-owned subsidiary Neelachal Ispat Nigam Limited (NINL), which reported negative net assets of ₹2,366 Cr as of March 31, 2025, into the parent to achieve operational synergies and simplify group structure. The Board also approved an investment of up to USD 2 Billion (~₹18,488.10 Cr) in wholly-owned subsidiary T Steel Holdings Pte. Ltd. (TSHP) for overseas operations and debt repayment, despite TSHP's total income declining sharply to ₹58.31 Cr in FY25 from ₹640.37 Cr in FY24. Additionally, approved acquisition of 49% equity and 31.85% preference stake in subsidiary Medica TS Hospital Private Limited for ₹1.49 Cr, making it wholly-owned.

• ·TSHP total income FY23: ₹1,089.60 Cr; PAT FY23: ₹(4,366.70) Cr; Net worth FY23: ₹19,699.87 Cr
• ·NINL registered office: Samabaya Bhawan, 4th Floor, Unit 9, Janpath, Bhoinagar, Khorda, Bhubaneswar, Odisha 751022
• ·Scheme subject to approvals under Sections 230-232 of Companies Act, 2013 and other laws
• ·Investment in TSHP from FY2026-27 onwards in one or more tranches
• ·No new shares issued or cash payment for NINL amalgamation; all shares cancelled
• ·Board meeting: March 17, 2026, 2:00 p.m. to 5:15 p.m. IST

17-03-2026

Tata Steel's Board approved a Scheme of Amalgamation with its wholly owned subsidiary Neelachal Ispat Nigam Limited (NINL), which has negative net assets of ₹2,366 Cr despite revenue of ₹5,701 Cr, aiming for operational synergies and structure simplification. The Board also approved investment of up to ₹18,488.10 Cr (USD 2 Billion) in wholly owned subsidiary T Steel Holdings Pte. Ltd. (with past losses including ₹4,367 Cr PAT in FY23) for overseas operations and debt repayment, and acquisition of 49% equity and 31.85% preference stake in Medica TS Hospital Private Limited for ₹1.49 Cr, making it wholly owned. These moves are subject to regulatory approvals.

• ·NINL operates integrated steel plant with 0.98 million tons per annum crude steel capacity and captive iron ore mine.
• ·TSHP investment to support overseas subsidiaries' capex, restructuring, and debt repayment from FY2026-27 in tranches.
• ·Board meeting held on March 17, 2026, from 2:00 p.m. to 5:15 p.m. IST.
• ·All transactions subject to necessary regulatory approvals under Companies Act, SEBI Listing Regulations, and other laws.

17-03-2026

R&B Denims Limited had a penalty of ₹43.66L imposed by the Assistant Commissioner of Central Goods and Services Tax, Gujarat, for an Input Tax Credit (ITC) availment issue, as announced on 18 April 2025. The appellate authority has now ruled in the company's favor, setting aside the penalty entirely. The company confirms no financial impact from this resolution.

• ·ISIN: INE012Q01021
• ·Scrip Code: 538119
• ·CIN: L17120GJ2010PLC062949
• ·Regulation: 30 of SEBI (LODR) Regulations, 2015

17-03-2026

Tata Steel's Board approved the Scheme of Amalgamation of its wholly-owned subsidiary Neelachal Ispat Nigam Limited (NINL, net assets -₹2,366 Cr, revenue ₹5,701 Cr as on March 31, 2025) into Tata Steel (net assets ₹1,26,732 Cr, revenue ₹1,32,517 Cr) to achieve synergies, simplify structure, and consolidate long products assets. The Board also approved investment of up to ₹18,488 Cr (USD 2 Bn) in wholly-owned subsidiary T Steel Holdings Pte Ltd from FY2026-27 for overseas operations support and debt repayment, and acquisition of 49% equity stake plus preference shares in Medica TS Hospital Private Limited for ₹1.49 Cr, making it wholly-owned. While the transactions aim at operational efficiencies and growth, NINL's negative net assets indicate potential integration costs.

• ·Neelachal Ispat Nigam Limited operates integrated steel plant with 0.98 MTPA crude steel capacity and holds captive iron ore mine lease.
• ·T Steel Holdings Pte. Ltd. total income declined sharply 90.9% YoY to ₹58.31 Cr in FY2025 but PAT improved to ₹0.21 Cr from loss; net worth grew 9.8% YoY.
• ·Post-amalgamation, no new shares issued by Tata Steel; NINL's equity and preference shares (including Tata Steel's holding of 45,60,54,252 NCPS) cancelled without cash consideration.
• ·Investment in T Steel Holdings Pte. Ltd. in one or more tranches from FY2026-27; scheme subject to approvals under Companies Act Sections 230-232.

17-03-2026

Mahindra & Mahindra Ltd. has informed stock exchanges about a scheduled plant visit for analysts and institutional investors on 23 March 2026 from 02:30 p.m. to 04:30 p.m. IST at their facility in Chakan Industrial Area, Pune. The event will be conducted in physical mode with no registration required or specific platform details, and the company has noted that the schedule may change due to exigencies. No unpublished price sensitive information will be shared during the visit.

• ·Venue: Plot no A1, Village Nighoje, Chakan Industrial Area, Phase IV, Chakan, Tal Khed, Pune 410501
• ·Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-03-2026

Mahindra & Mahindra Ltd. virtually participated in the Nomura India Corporate Day on March 17, 2026, in Mumbai, engaging with funds and investors, with the event concluding at 8.25 p.m. IST. The company presented materials from its Q3 FY26 Analyst Meet deck submitted on February 11, 2026, which is available on its website. No unpublished price-sensitive information was shared, in compliance with SEBI (LODR) Regulations, 2015.

• ·Advance intimation provided via letter dated March 10, 2026
• ·Presentation weblink: M&M Q3F26 Analyst Meet – Presentations deck – 11th February 2026
• ·Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-03-2026

Sun Pharmaceutical Industries Limited announced the launch of a Shareholder Satisfaction Survey to gather feedback on services provided by its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime India Private Limited). The survey commences on March 17, 2026, and remains open until March 31, 2026, limited to shareholders who availed RTA services from April 1, 2025, to December 31, 2025, with invitations sent via email. This initiative aims to improve efficiency, service quality, and shareholder engagement.

• ·ICSI Membership No.: A23983
• ·Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA
• ·Corporate Office: Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA
• ·CIN: L24230GJ1993PLC019050
• ·Scrip Symbol: SUNPHARMA (NSE), Scrip Code: 524715 (BSE)

17-03-2026

Maruti Suzuki India Limited received a Draft Assessment Order from the Income Tax Authority on March 16, 2026, for FY 2022-23, proposing additions/disallowances amounting to ₹5,786.4 Cr with respect to the returned income. The company intends to file objections before the Dispute Resolution Panel. It states there is no impact on financial, operational, or other activities due to this draft order.

• ·Intimation disclosed under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

17-03-2026

Kilitch Drugs (India) Limited has fixed Tuesday, March 24, 2026, as the Record Date pursuant to Regulation 42 of SEBI LODR to determine shareholders entitled to bonus equity shares in the ratio of 1:1 (one bonus equity share of Rs. 10/- for every one equity share of Rs. 10/- held). The deemed date of allotment of the bonus shares is Wednesday, March 25, 2026, following shareholder approval. Shareholders registered on the Company's register or with depositories by the closing hours of the Record Date will be eligible.

• ·Scrip Code: BSE - 524500, NSE - KILITCH
• ·CIN: L24239MH1992PLCO66718
• ·Registered Office: C-301/2, M.I.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705, Maharashtra